TSI Group Co., Ltd. (SHA:603262)

Market Cap	7.69B -37.8%
Revenue (ttm)	1.04B -3.1%
Net Income	109.07M -38.8%
EPS	0.27 -46.5%
Shares Out	400.01M
PE Ratio	70.47
Forward PE	n/a
Dividend	0.09 (0.45%)
Ex-Dividend Date	Jul 17, 2026

Volume	3,665,635
Open	19.52
Previous Close	19.52
Day's Range	19.22 - 19.85
52-Week Range	17.42 - 33.12
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About TSI Group

TSI Group Co., Ltd. engages in the discovery, development, manufacturing, and sale of vitamins and dietary supplements for healthy lifestyles worldwide. It offers vegan glucosamine under the GlucosaGreen brand; ß-hydroxy ß-methylbutyrate, a nutritional solution under the myHMB brand; adenosine 5’- triphosphate under the PEAK ATP brand for body composition and athletic performance; 2-hydroxybenzylamine, a naturally occurring compound that support cellular health; enfinity, a downstream metabolite of caffeine; vitamins and dietary supplements und...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1996
• Country: China
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603262

Financial Performance

In 2025, TSI Group's revenue was 1.09 billion, an increase of 9.10% compared to the previous year's 1.00 billion. Earnings were 133.69 million, a decrease of -23.36%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 4, 2026

Data Sources Report a data error